GeNOsys, which specializes in pharmaceutical, biotechnical and medical gas generating systems, has signed a service contract with the University of British Columbia. The service contract is for a period of one year.
Subscribe to our email newsletter
Under the service contract, the University of British Columbia (UBC) will conduct research at the UBC Department of Medicine, and the Vancouver Coastal Health Research Institute, which conducts and coordinates research in support of international programs for infectious disease control and prevention.
The research will be conducted under the direction of Dr Yossef Av-Gay. Dr Av-Gay’s laboratory research is focused on the molecular pathogenesis of Mycobacterium tuberculosis and identification of new targets for drug therapy.
Clark Mower, chairman of the board at GeNOsys, said: “We feel extremely fortunate to be able to contract with Dr Av-Gay. He is highly qualified and has won international respect and acclaim for his work with tuberculosis. We look forward with great anticipation toward the results of his research utilizing our generator and nitric oxide delivery method and feel it will enable us, with documented laboratory research results, to advance toward animal and then clinical trials.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.